Net Cash Provided by (Used in) Financing Activities in USD of NEVRO CORP from 2016 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
NEVRO CORP quarterly and annual Net Cash Provided by (Used in) Financing Activities history and change rate from 2016 to 2024.
  • NEVRO CORP Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2024 was $6,480,000, a 185% decline year-over-year.
  • NEVRO CORP annual Net Cash Provided by (Used in) Financing Activities for 2024 was $4,205,000, a 108% decline from 2023.
  • NEVRO CORP annual Net Cash Provided by (Used in) Financing Activities for 2023 was $49,534,000.
  • NEVRO CORP annual Net Cash Provided by (Used in) Financing Activities for 2022 was $2,457,000, a 99% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

NEVRO CORP Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $6,480,000 -$4,207,000 -185% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q1 2023 $2,273,000 +$4,480,000 +66% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $6,753,000 -$5,283,000 -359% 01 Jan 2022 31 Mar 2022 10-Q 26 Apr 2023 2023 Q1
Q1 2021 $1,470,000 -$17,648,000 -109% 01 Jan 2021 31 Mar 2021 10-Q 04 May 2022 2022 Q1
Q1 2020 $16,178,000 +$14,404,000 +812% 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1
Q1 2019 $1,774,000 +$48,000 +2.8% 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q1
Q1 2018 $1,726,000 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1

NEVRO CORP Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $4,205,000 -$53,739,000 -108% 01 Jan 2024 31 Dec 2024 10-K 04 Mar 2025 2024 FY
2023 $49,534,000 +$51,991,000 01 Jan 2023 31 Dec 2023 10-K 04 Mar 2025 2024 FY
2022 $2,457,000 +$166,924,000 +99% 01 Jan 2022 31 Dec 2022 10-K 04 Mar 2025 2024 FY
2021 $169,381,000 -$516,286,000 -149% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2024 2023 FY
2020 $346,905,000 +$314,812,000 +981% 01 Jan 2020 31 Dec 2020 10-K 21 Feb 2023 2022 FY
2019 $32,093,000 +$24,339,000 +314% 01 Jan 2019 31 Dec 2019 10-K 23 Feb 2022 2021 FY
2018 $7,754,000 -$3,445,000 -31% 01 Jan 2018 31 Dec 2018 10-K 24 Feb 2021 2020 FY
2017 $11,199,000 -$133,965,000 -92% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $145,164,000 01 Jan 2016 31 Dec 2016 10-K 21 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.